President Trump this week signed into law comprehensive legislation aimed at slowing the nation’s opioid crisis. The 250-page bill called The Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (H.R.6):
The bill, which passed the House and Senate earlier this year with bipartisan support, also requires The Centers for Medicare & Medicaid Services (CMS) to establish a demonstration project to increase provider treatment capacity for substance-use disorders. New Medicare enrollees must include an opioid-use disorder screening and prescription history review and Medicare prescription drug plan sponsors must establish drug-management programs for at-risk beneficiaries.